Loading organizations...
§ Venture Capital · Jefferson City, MO, USA
ROVAQ Ventures operates as a venture capital firm, deploying strategic capital across pre-seed, seed, and late-stage investment rounds. The firm targets a diverse portfolio within high-growth sectors, primarily focusing on healthcare, biotechnology, drug discovery, information technology, and agricultural technology. It fosters innovation and accelerates development of transformative companies in these specialized domains.
Established in 2019, ROVAQ Ventures operates from Jefferson City, Missouri, with a strategic focus on the United States market. The firm's inception demonstrates a commitment to deploying capital and expertise for emerging and scaling businesses. Its formation addresses demand for specialized investment in industries marked by significant technological advancement.
The firm partners with a broad spectrum of companies, from foundational startups to expanding enterprises requiring growth capital. ROVAQ Ventures' vision is to serve as a pivotal financial partner for innovators, enabling concepts to become market-leading solutions. They cultivate a dynamic portfolio that drives progress and generates meaningful returns across selected industry verticals.
ROVAQ Ventures has 1 tracked investment across 1 company. The latest tracked deal is $21.0M Series B in ImmunoPhotonics in April 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2022 | ImmunoPhotonics | $21.0M Series B | Rovaq Ventures, Zubizoom Investments | Andrew Wheeler, ISelect Fund, Mercury Fund, Prelude Ventures, VantagePoint Capital Partners, Immune |